Logo

warrants

Applied DNA Prices $12M Public Stock, Warrant Offering

The company, which develops molecular diagnostics and manufactures DNA, closed a roughly $4.2 million registered direct stock offering earlier this year.

SQI Diagnostics Raises C$3.9M From Warrant Exercise

Earlier this year, SQI grossed around C$4 million from the exercise of similar common share purchase warrants.

Progenity Enters $25M Private Placement

The company will issue units representing an aggregate of shares of common stock and warrants to purchase stock shares at an aggregate purchase price of $5.72.

OpGen Enters $25M Direct Offering Agreement

A single healthcare-focused investor will purchase 2.78 million shares of common stock, 5.55 million prefunded warrants, and an additional 4.17 million shares of common stock.

SQI Diagnostics Nabs C$4M From Exercise of Warrants

The proceeds will go toward the clinical development, regulatory submission, and commercialization of three of its COVID-19 tests.